{"id":"https://openalex.org/W4412046513","doi":"https://doi.org/10.1007/s40121-025-01172-9","title":"Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention","display_name":"Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention","publication_year":2025,"publication_date":"2025-07-05","ids":{"openalex":"https://openalex.org/W4412046513","doi":"https://doi.org/10.1007/s40121-025-01172-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/40616767"},"language":"en","primary_location":{"id":"doi:10.1007/s40121-025-01172-9","doi":"https://doi.org/10.1007/s40121-025-01172-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-025-01172-9","pdf_url":null,"source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s40121-025-01172-9","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003412990","display_name":"Neil Hawkins","orcid":"https://orcid.org/0000-0003-3199-221X","observed_orcids":["https://orcid.org/0000-0003-3199-221X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil Hawkins","raw_affiliation_strings":["Visible Analytics Ltd, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0003-3199-221X","affiliations":[{"raw_affiliation_string":"Visible Analytics Ltd, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062428798","display_name":"Paul D. O\u2019Brien","orcid":"https://orcid.org/0000-0002-6064-8023","observed_orcids":["https://orcid.org/0000-0002-6064-8023"]},"institutions":[{"id":"https://openalex.org/I4210103149","display_name":"ViiV Healthcare (United Kingdom)","ror":"https://ror.org/01cc9yk21","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210103149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul O\u2019Brien","raw_affiliation_strings":["ViiV Healthcare, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-6064-8023","affiliations":[{"raw_affiliation_string":"ViiV Healthcare, London, UK","institution_ids":["https://openalex.org/I4210103149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086694459","display_name":"Juliette Catherine Thompson","orcid":"https://orcid.org/0000-0001-7646-9460","observed_orcids":["https://orcid.org/0000-0001-7646-9460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliette Thompson","raw_affiliation_strings":["Visible Analytics Ltd, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0001-7646-9460","affiliations":[{"raw_affiliation_string":"Visible Analytics Ltd, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023247190","display_name":"Sarah\u2010Jane Anderson","orcid":"https://orcid.org/0000-0002-5945-2285","observed_orcids":["https://orcid.org/0000-0002-5945-2285"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah-Jane Anderson","raw_affiliation_strings":["GSK, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, London, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081828204","display_name":"Eric Julian Manalastas","orcid":"https://orcid.org/0000-0002-6907-4302","observed_orcids":["https://orcid.org/0000-0002-6907-4302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Manalastas","raw_affiliation_strings":["Visible Analytics Ltd, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-6907-4302","affiliations":[{"raw_affiliation_string":"Visible Analytics Ltd, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056292456","display_name":"L. Benjamin","orcid":"https://orcid.org/0000-0001-7748-0768","observed_orcids":["https://orcid.org/0000-0001-7748-0768"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Laure Dupont-Benjamin","raw_affiliation_strings":["ViiV Healthcare, 23 Rue Fran\u00e7ois Jacob, 92500, Rueil-Malmaison, France. laure.x.dupontbenjamin@viivhealthcare.com"],"raw_orcid":"https://orcid.org/0000-0001-7748-0768","affiliations":[{"raw_affiliation_string":"ViiV Healthcare, 23 Rue Fran\u00e7ois Jacob, 92500, Rueil-Malmaison, France. laure.x.dupontbenjamin@viivhealthcare.com","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019669640","display_name":"Melanie Schroeder","orcid":"https://orcid.org/0000-0003-0338-1331","observed_orcids":["https://orcid.org/0000-0003-0338-1331"]},"institutions":[{"id":"https://openalex.org/I4210103149","display_name":"ViiV Healthcare (United Kingdom)","ror":"https://ror.org/01cc9yk21","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210103149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Melanie Schroeder","raw_affiliation_strings":["ViiV Healthcare, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViiV Healthcare, London, UK","institution_ids":["https://openalex.org/I4210103149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5056292456"],"corresponding_institution_ids":[],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":2.1959,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.86992639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"14","issue":"8","first_page":"1739","last_page":"1753"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabotegravir","display_name":"cabotegravir","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.7540000081062317},{"id":"https://openalex.org/keywords/emtricitabine-tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate/emtricitabine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hiv-acquisition","display_name":"HIV acquisition","score":0.6439999938011169},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.8610000014305115},{"id":"https://openalex.org/keywords/prep-effectiveness","display_name":"PrEP effectiveness","score":0.5519999861717224},{"id":"https://openalex.org/keywords/generalizability-of-trial-results","display_name":"generalizability of trial results","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.9290846586227417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9023527503013611},{"id":"https://openalex.org/C2778283251","wikidata":"https://www.wikidata.org/wiki/Q1361206","display_name":"Post-exposure prophylaxis","level":3,"score":0.5608312487602234},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5465022921562195},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26323556900024414},{"id":"https://openalex.org/C2776939746","wikidata":"https://www.wikidata.org/wiki/Q853451","display_name":"Men who have sex with men","level":4,"score":0.07168689370155334},{"id":"https://openalex.org/C2776983459","wikidata":"https://www.wikidata.org/wiki/Q41083","display_name":"Syphilis","level":3,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s40121-025-01172-9","doi":"https://doi.org/10.1007/s40121-025-01172-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-025-01172-9","pdf_url":null,"source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},{"id":"pmid:40616767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40616767","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious diseases and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.gla.ac.uk:378505","doi":null,"is_oa":true,"landing_page_url":"https://eprints.gla.ac.uk/view/author/17393.html>","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Articles"},{"id":"pmh:oai:pubmedcentral.nih.gov:12339807","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12339807","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infect Dis Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:64edcaa3b38940dc8c676d16d0c941d2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/64edcaa3b38940dc8c676d16d0c941d2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infectious Diseases and Therapy, Vol 14, Iss 8, Pp 1739-1753 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40121-025-01172-9","doi":"https://doi.org/10.1007/s40121-025-01172-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-025-01172-9","pdf_url":null,"source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6700000166893005}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320312382","display_name":"ViiV Healthcare","ror":"https://ror.org/01cc9yk21"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1413161224","https://openalex.org/W2000761749","https://openalex.org/W2044369525","https://openalex.org/W2103920597","https://openalex.org/W2117057469","https://openalex.org/W2134966461","https://openalex.org/W2162226934","https://openalex.org/W2168251450","https://openalex.org/W2298072787","https://openalex.org/W2319917590","https://openalex.org/W2464724361","https://openalex.org/W2508961927","https://openalex.org/W2550605679","https://openalex.org/W2598366255","https://openalex.org/W2794993672","https://openalex.org/W2808100257","https://openalex.org/W2939980532","https://openalex.org/W2976283532","https://openalex.org/W2990035314","https://openalex.org/W3090027381","https://openalex.org/W3190424399","https://openalex.org/W4220828731","https://openalex.org/W4225714348","https://openalex.org/W4226116413","https://openalex.org/W4229053303","https://openalex.org/W4229456555","https://openalex.org/W4280565035","https://openalex.org/W4283639609","https://openalex.org/W4315434502","https://openalex.org/W4382023334","https://openalex.org/W4382139179","https://openalex.org/W4400958746","https://openalex.org/W4404784297"],"related_works":["https://openalex.org/W2883964143","https://openalex.org/W3010773016","https://openalex.org/W4394495993","https://openalex.org/W4400934858","https://openalex.org/W2255006083","https://openalex.org/W2890395329","https://openalex.org/W2768983933","https://openalex.org/W2888490071","https://openalex.org/W3086345252","https://openalex.org/W1914242510"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,143,148,160,223],"efficacy":[2,249],"of":[3,57,66,76,119,163,184,203,225,233,248,257,269],"long-acting":[4],"injectable":[5,82],"cabotegravir":[6,58,204,226,234,271],"(hereafter":[7],"referred":[8],"to":[9,50,112,277],"as":[10],"cabotegravir)":[11],"versus":[12,59,166,205,227],"daily":[13],"oral":[14,67,77,80,88,104,123,155,164,261],"tenofovir":[15],"disoproxil":[16],"fumarate/emtricitabine":[17],"(TDF/FTC)":[18],"for":[19,171,210,293],"pre-exposure":[20],"prophylaxis":[21],"(PrEP)":[22],"was":[23,97,110,131,169,208],"demonstrated":[24],"in":[25,103,128,187,214,236,252,284],"two":[26],"phase":[27],"3":[28],"randomized":[29],"controlled":[30],"trials":[31,40,75,109,276,287],"(RCTs),":[32],"HPTN":[33,36,172,177,193,215,219,238,275],"083":[34,173,189,216,239],"and":[35,81,87,121,158,218,240,260,280],"084.":[37],"As":[38],"these":[39,286],"did":[41],"not":[42],"have":[43],"a":[44,117,137,151,244],"no-PrEP":[45],"group,":[46],"this":[47,294],"analysis":[48,144],"aimed":[49],"perform":[51],"an":[52,134],"indirect":[53],"treatment":[54],"comparison":[55],"(ITC)":[56],"no":[60,167,206,228],"PrEP":[61,83,89,124,168,207,229],"via":[62],"the":[63,181,198,200,237,267,270],"common":[64],"comparator":[65],"TDF/FTC.":[68],"METHODS:":[69],"A":[70],"systematic":[71],"literature":[72],"review":[73],"identifying":[74],"or":[78,126],"both":[79,211,274],"reporting":[84],"HIV":[85,129,258],"acquisition":[86],"adherence,":[90],"measured":[91],"by":[92],"detectable":[93],"TDF/FTC":[94,105,156,165,262],"plasma":[95],"levels,":[96],"conducted":[98],"(November":[99],"1,":[100],"2023).":[101],"Heterogeneity":[102],"adherence":[106,120,157,185],"level":[107,183,247],"between":[108,154],"expected":[111],"confound":[113],"ITC":[114,135,224],"estimates;":[115],"therefore,":[116],"meta-regression":[118,149],"resulting":[122],"effectiveness,":[125],"reduction":[127],"acquisition,":[130,259],"incorporated":[132],"into":[133],"using":[136],"joint":[138],"Bayesian":[139],"model":[140],"framework.":[141],"RESULTS:":[142],"included":[145],"ten":[146],"RCTs.":[147],"showed":[150],"strong":[152],"relationship":[153],"effectiveness.":[159],"predicted":[161,201,230],"effectiveness":[162,202,235],"greater":[170],"(77%)":[174],"compared":[175,191],"with":[176,192],"084":[178,194,220,241],"(47%),":[179],"reflecting":[180],"higher":[182],"observed":[186],"HTPN":[188],"(86%)":[190],"(56%).":[195],"Based":[196],"on":[197],"ITC,":[199],"similar":[209,231],"populations":[212,279],"investigated":[213],"(92%)":[217],"(93%).":[221],"CONCLUSIONS:":[222],"estimates":[232,265],"trials,":[242],"suggesting":[243],"very":[245],"high":[246],"despite":[250],"differences":[251],"population,":[253],"setting,":[254],"underlying":[255],"rate":[256],"adherence.":[263],"These":[264],"support":[266],"generalizability":[268],"results":[272],"from":[273],"other":[278],"regions":[281],"than":[282],"those":[283],"which":[285],"were":[288],"conducted.":[289],"Graphical":[290],"abstract":[291],"available":[292],"article.":[295]},"counts_by_year":[{"year":2026,"cited_by_count":3}],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2025-10-10T00:00:00"}